AI-generated summary
The authors randomized 42 patients with unilateral temporomandibular disorders to either four weeks of photobiomodulation therapy or four weeks of a combination pain tablet (MEGAFEN). They report that photobiomodulation was associated with lower pain, better mouth opening, and less joint clicking and tenderness at day 28, with no significant difference in lateral excursion. The authors note that further investigation is needed to establish a standard laser protocol.
- Participants
- 42
- Who or what was studied
- Patients diagnosed with unilateral temporomandibular disorders
- Limits stated in the abstract
- The abstract does not report the wavelength, dose or device used for the photobiomodulation protocol, and the trial was single-blind.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.